Literature DB >> 8448139

Phosphomannose isomerase from Saccharomyces cerevisiae contains two inhibitory metal ion binding sites.

T N Wells1, F Coulin, M A Payton, A E Proudfoot.   

Abstract

Phosphomannose isomerase (PMI) from Saccharomyces cerevisiae is a zinc-dependent metalloenzyme. Besides its role in catalysis, zinc is also a potent inhibitor of the enzyme. The inhibition is competitive with the substrate mannose 6-phosphate, with Kis = 6.4 microM in 50 mM Tris-HCl buffer, pH 8.0, at 37 degrees C. This inhibition constant is 4 orders of magnitude smaller than for group II divalent cations, indicating that the binding is not primarily electrostatic. Micromolar inhibition is also observed with ions of the other metals of the electronic configuration d10. Under identical conditions, cadmium is a predominantly competitive inhibitor with Kis = 19.5 microM. Inhibition by mercury is predominantly competitive with Kis = 6.0 microM but shows a hyperbolic Dixon plot. Theorell-Yonetani double-inhibition analysis shows that zinc and cadmium ions are mutually exclusive inhibitors against mannose 6-phosphate. However, analysis of zinc and mercury double inhibition shows that they can simultaneously bind in the mannose 6-phosphate binding pocket, with only a small mutual repulsion. Inhibition of the enzyme by cadmium and zinc ions is strongly pH dependent with pKa = 9.2 for cadmium and one pKa at 6.6 and two at 8.9 for zinc. The inhibitory species are the monohydroxide forms, Zn(OH)+ and Cd(OH)+. However, inhibition by mercury is relatively pH-independent, consistent with the neutral Hg(OH)2 being the inhibitory species. In all three cases, the metal ion binding causes a conformational change in the enzyme as judged by tryptophan fluorescence.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8448139     DOI: 10.1021/bi00056a014

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Phosphomannose isomerase of Xanthomonas campestris: a zinc activated enzyme.

Authors:  S V Papoutsopoulou; D A Kyriakidis
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

2.  In vivo and in vitro folding of a recombinant metalloenzyme, phosphomannose isomerase.

Authors:  A E Proudfoot; L Goffin; M A Payton; T N Wells; A R Bernard
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

3.  Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy.

Authors:  R Niehues; M Hasilik; G Alton; C Körner; M Schiebe-Sukumar; H G Koch; K P Zimmer; R Wu; E Harms; K Reiter; K von Figura; H H Freeze; H K Harms; T Marquardt
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

4.  Purification and characterization of fungal and mammalian phosphomannose isomerases.

Authors:  A E Proudfoot; M A Payton; T N Wells
Journal:  J Protein Chem       Date:  1994-10

5.  Arabidopsis phosphomannose isomerase 1, but not phosphomannose isomerase 2, is essential for ascorbic acid biosynthesis.

Authors:  Takanori Maruta; Miki Yonemitsu; Yukinori Yabuta; Masahiro Tamoi; Takahiro Ishikawa; Shigeru Shigeoka
Journal:  J Biol Chem       Date:  2008-08-28       Impact factor: 5.157

6.  Characterization of a Mannose-6-Phosphate Isomerase from Bacillus amyloliquefaciens and Its Application in Fructose-6-Phosphate Production.

Authors:  Sujan Sigdel; Ranjitha Singh; Tae-Su Kim; Jinglin Li; Sang-Yong Kim; In-Won Kim; Woo-Suk Jung; Cheol-Ho Pan; Yun Chan Kang; Jung-Kul Lee
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

Review 7.  Cell organelles as targets of mammalian cadmium toxicity.

Authors:  Wing-Kee Lee; Frank Thévenod
Journal:  Arch Toxicol       Date:  2020-03-23       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.